Vineet Laboratories Rights Issue 2025 Details, Record Date, Issue Price

Vineet Laboratories Rights Issue details are now available. The firm plans to issue 99,87,258 equity shares amounting to Rs 29.96 crores. Vineet Laboratories Rights issue price is Rs 30 per share, and the face value is Rs 10 per share.

Vineet Laboratories Rights Issue open date is January 1, 2025, and the close date is January 21, 2025. Vineet Laboratories rights issue entitlement ratio is 13:12, which is 13 Rights Equity Shares for every 12 fully paid-up Equity Shares held on the record date.

Vineet Laboratories Rights Issue record date is December 23, 2025. The last date to buy shares of Vineet Laboratories is December 22, 2025. This rights Issue subscription status will be available soon.

Vineet Laboratories Rights Issue Allotment date, Credit and the Listing date will be available soon. However, the listing will be on the BSE and NSE platforms.

Vineet Laboratories Limited's rights issue registrar is Bigshare Services Pvt.Ltd. and the book-running lead manager(s) for this rights issue will be available soon.

Also Read | Deccan Gold Mines Rights Issue 2025 Details, Record Date, Issue Price

Vineet Laboratories Rights Issue Details

Vineet Laboratories Rights Issue details are as follows: the company plans to issue 99,87,258 equity shares, aggregating the amount of Rs 29.96 crores. Vineet Laboratories Rights issue price is Rs 30 per share. The rights issue entitlement ratio is 13:12, which is 13 Rights Equity Shares for every 12 fully paid-up equity share(s).

Vineet Laboratories Rights Issue Dates

Vineet Laboratories Rights issue record date is December 23, 2025, 2025, and the last date to buy shares of Vineet Laboratories is December 22, 2025.

Vineet Laboratories Rights Issue Subscription

Vineet Laboratories Rights Issue subscription status will be available after the issue goes live. The details of the Rights Issue entitlement are 13 Rights Equity Share(s) for every 12 fully paid-up Equity Share(s) held on the Record Date. Vineet Laboratories issue price is Rs 30 per share.

Vineet Laboratories Limited: About the Company

Vineet Laboratories Limited, established in 2007 in Malkapur, Telangana, focuses on manufacturing pharmaceutical intermediates and fine chemicals from its ISO 9001:2015-certified facility. Equipped with 230KL reactors handling extreme temperatures down to -100°C, the plant produces key API precursors for drugs like Lopinavir, Ritonavir, Efavirenz, and Glimepiride, plus specialties such as IPTG and n-Butyl Lithium. Founder Gaddam Venkata Ramana brings over 30 years of expertise, guiding custom synthesis for multinational clients under ICH Q7 standards, with rigorous quality checks via multiple HPLCs and GCs.

Recent developments include a Rs 29.96 crore rights issue approved at Rs 30 per share in a 13:12 ratio, record date December 23, 2025, opening January 1, 2026, to support expansion amid revenue dips. The company eyes an advanced R&D center for innovative molecules and adheres to ISO 14001:2015 for eco-friendly operations, cutting effluents while serving global pharma needs through process innovation and audits.

Vineet Laboratories Limited Financials (Amount in Rs crore)

Vineet Laboratories Rights Issue Registrar

Vineet Laboratories rights issue registrar is Bigshare Services Pvt.Ltd. and the book-running lead manager(s) for this rights issue will be available soon.

FAQs

1. What are the details of the Vineet Laboratories Rights Issue?

Vineet Laboratories Rights Issue details are as follows: Vineet Laboratories plans to issue 99,87,258 equity shares amounting to Rs 29.96 crores. Vineet Laboratories Rights issue price is Rs 30 per share, and the face value is Rs 10 per share. The rights issue entitlement ratio is 13:12, which is 13 Rights Equity Share(s) for every 12 fully paid-up equity share(s).

2. Vineet Laboratories Rights Issue open date and close date?

Vineet Laboratories Rights Issue's open date is January 1, 2025, and the closing date is January 21, 2025. Vineet Laboratories Rights Issue record date is December 23, 2025, 2025. The last date to buy shares of Vineet Laboratories is December 22, 2025.

3. How can I apply for the Vineet Laboratories Rights Issue?

You can apply for Vineet Laboratories in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).

4. What is the entitlement ratio for the Vineet Laboratories Rights Issue?

Vineet Laboratories rights issue entitlement ratio is 13:12, which is 13 Rights Equity Share(s) for every 12 fully paid-up equity share(s).

5. How can I check the Vineet Laboratories Issue Allotment Status?

The registrar for this upcoming rights issue is Bigshare Services Pvt.Ltd. Investors can check the allotment status by visiting the registrar's website.

6. From where can I get the Vineet Laboratories Rights issue Letter of Offer?

You can download the Vineet Laboratories Rights Issue Letter of Offer by visiting here.

7. What is the listing date of the Vineet Laboratories Rights Issue?

The Vineet Laboratories Rights Issue listing date is not yet available. However, the listing will be on the BSE and NSE exchanges.

8. Who are the registrar and lead managers of the Vineet Laboratories Rights Issue?

Vineet Laboratories rights issue registrar is Bigshare Services Pvt.Ltd. and the book-running lead manager(s) for this rights issue have will be available soon.

Also Read | Nacl Industries Rights Issue 2025 Details, Record Date, Issue Price